{
    "Trade/Device Name(s)": [
        "Virtual Slide System",
        "OLYMPUS VS800 System",
        "VS800 HER2 MR Application"
    ],
    "Submitter Information": "OLYMPUS CORPORATION",
    "510(k) Number": "K111914",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071671"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OEO"
    ],
    "Summary Letter Date": "August 13, 2012",
    "Summary Letter Received Date": "August 15, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.1860"
    ],
    "Regulation Name(s)": [
        "Immunohistochemistry reagents and kits"
    ],
    "Analyte Class(es)": [
        "anatomic pathology",
        "cancer molecular"
    ],
    "Analyte(s)": [
        "HER2"
    ],
    "Specimen Type(s)": [
        "Formalin-fixed, paraffin-embedded normal and neoplastic tissue",
        "Breast tissue"
    ],
    "Specimen Container(s)": [
        "Glass microscope slide"
    ],
    "Instrument(s)/Platform(s)": [
        "VS800-SS automated digital microscope slide scanner",
        "VS800-MTR operating monitor",
        "VS Viewer software (VS2-ASW-IDB)"
    ],
    "Method(s)/Technology(ies)": [
        "Digital slide scanning",
        "Colorimetric pattern recognition",
        "Manual digital review"
    ],
    "Methodologies": [
        "Immunohistochemistry",
        "Digital pathology information management",
        "Manual examination"
    ],
    "Submission Type(s)": [
        "System",
        "Accessory",
        "Software",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for Olympus VS800 automated digital slide system and HER2 Manual Read application for digital pathology and breast cancer HER2 assessment",
    "Indications for Use Summary": "Intended as an aid to pathologists for digital display, detection, counting, and classification of tissues and cells of clinical interest, including semi-quantitative measurement of HER2 in breast cancer tissue immunohistochemically stained for HER2 receptors; as an accessory to Dako HercepTest to assist in assessing breast cancer patients considered for Herceptin (Trastuzumab) therapy.",
    "fda_folder": "Hematology"
}